Innoviva (INVA) FCF Payout Ratio (QoQ) (2015 - 2022)
Powered by 
Analysis
Innoviva (INVA) FCF Payout Ratio (QoQ) (2015 - 2022) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Innoviva | 1.56 Bn | 984.81 Mn | 90.62 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | 199.72% |
| Jun 30, 2022 | 82.13% |
| Sep 30, 2021 | -26.70% |
| Jun 30, 2021 | -5.85% |
| Mar 31, 2021 | 759.15% |
| Jun 30, 2020 | -29.23% |
| Sep 30, 2019 | 345,753.71% |
| Jun 30, 2019 | -49.12% |
| Mar 31, 2019 | -99.79% |
| Dec 31, 2018 | 50.05% |
| Sep 30, 2018 | 111.55% |
| Jun 30, 2018 | 767.42% |
| Mar 31, 2018 | -36.08% |
| Dec 31, 2017 | 214.55% |
| Sep 30, 2017 | -49.25% |
| Jun 30, 2017 | -26.79% |
| Mar 31, 2017 | -21.81% |
| Dec 31, 2016 | 18.40% |
| Sep 30, 2016 | -73.82% |
| Jun 30, 2016 | -89.96% |